Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Public sources
Chapter 2 Executive Summary
2.1 Pet diabetes care devices industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Device type trends
2.1.3 Animal type trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Pet Diabetes Care Devices Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of pet diabetes across the globe
3.3.1.2 Increasing pet healthcare expenditure
3.3.1.3 Growing incidence of obesity in pets
3.3.2 Industry pitfalls & challenges
3.3.2.1 Side effects associated with diabetes medications
3.4 Growth potential analysis
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Germany
3.6.3 UK
3.6.4 France
3.6.5 Italy
3.6.6 Australia
3.6.7 South Africa
3.7 PESTEL analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Competitive analysis of major market players
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 Pet Diabetes Care Devices Market, By Device Type
5.1 Key segment trends
5.2 Glucose monitoring devices
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Insulin delivery devices
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2 Insulin delivery pen
5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.3 Insulin syringes
5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Pet Diabetes Care Devices Market, By Animal Type
6.1 Key segment trends
6.2 Cats
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Dogs
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Horses
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Pet Diabetes Care Devices Market, By End-use
7.1 Key segment trends
7.2 Veterinary clinics
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Home care settings
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Veterinary hospitals
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Pet Diabetes Care Devices Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018 - 2032 (USD Million)
8.2.2 Market size, by device type, 2018 - 2032 (USD Million)
8.2.2.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.2.3 Market size, by animal type, 2018 - 2032 (USD Million)
8.2.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by device type, 2018 - 2032 (USD Million)
8.2.5.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.2.5.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.2.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by device type, 2018 - 2032 (USD Million)
8.2.6.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.2.6.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.2.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018 - 2032 (USD Million)
8.3.2 Market size, by device type, 2018 - 2032 (USD Million)
8.3.2.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.3 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by device type, 2018 - 2032 (USD Million)
8.3.5.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.5.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by device type, 2018 - 2032 (USD Million)
8.3.6.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.6.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by device type, 2018 - 2032 (USD Million)
8.3.7.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.7.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.8 Spain
8.3.8.1 Market size, by device type, 2018 - 2032 (USD Million)
8.3.8.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.8.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.9 Italy
8.3.9.1 Market size, by device type, 2018 - 2032 (USD Million)
8.3.9.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.9.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.10 Denmark
8.3.10.1 Market size, by device type, 2018 - 2032 (USD Million)
8.3.10.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.10.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.10.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.11 The Netherlands
8.3.11.1 Market size, by device type, 2018 - 2032 (USD Million)
8.3.11.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.3.11.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.3.11.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018 - 2032 (USD Million)
8.4.2 Market size, by device type, 2018 - 2032 (USD Million)
8.4.2.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.4.3 Market size, by animal type, 2018 - 2032 (USD Million)
8.4.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.5 China
8.4.5.1 Market size, by device type, 2018 - 2032 (USD Million)
8.4.5.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.4.5.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.4.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.6 India
8.4.6.1 Market size, by device type, 2018 - 2032 (USD Million)
8.4.6.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.4.6.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.4.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.7 Japan
8.4.7.1 Market size, by device type, 2018 - 2032 (USD Million)
8.4.7.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.4.7.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.4.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by device type, 2018 - 2032 (USD Million)
8.4.8.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.4.8.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.4.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.9 South Korea
8.4.9.1 Market size, by device type, 2018 - 2032 (USD Million)
8.4.9.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.4.9.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.4.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018 - 2032 (USD Million)
8.5.2 Market size, by device type, 2018 - 2032 (USD Million)
8.5.2.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.5.3 Market size, by animal type, 2018 - 2032 (USD Million)
8.5.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.5 Brazil
8.5.5.1 Market size, by device type, 2018 - 2032 (USD Million)
8.5.5.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.5.5.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.5.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.6 Mexico
8.5.6.1 Market size, by device type, 2018 - 2032 (USD Million)
8.5.6.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.5.6.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.5.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.7 Argentina
8.5.7.1 Market size, by device type, 2018 - 2032 (USD Million)
8.5.7.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.5.7.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.5.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2018 - 2032 (USD Million)
8.6.2 Market size, by device type, 2018 - 2032 (USD Million)
8.6.2.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.6.3 Market size, by animal type, 2018 - 2032 (USD Million)
8.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.5 South Africa
8.6.5.1 Market size, by device type, 2018 - 2032 (USD Million)
8.6.5.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.6.5.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.6.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.6 Saudi Arabia
8.6.6.1 Market size, by device type, 2018 - 2032 (USD Million)
8.6.6.1.1 Market size, by insulin delivery devices, 2018 - 2032 (USD Million)
8.6.6.2 Market size, by animal type, 2018 - 2032 (USD Million)
8.6.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
Chapter 9 Company Profiles
9.1 Merck Animal Health
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Service landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 Allison Medical
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Service landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Boehringer Ingelheim Vetmedica Inc.
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Service landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Becton, Dickinson and Company
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Service landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 FitBark
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Service landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Henry Schein Animal Health
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Service landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Ulticare
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Service landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 TaiDoc
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Service landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Zoetis
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Service landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Teco Diagnostics
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Service landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
